BIOCRYST PHARMACEUTICALS INC (BCRX) › Net IncomeBIOCRYST PHARMACEUTICALS INC (BCRX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$13.45M2010: -$33.85M2011: -$56.95M2012: -$39.08M2013: -$30.11M2014: -$45.19M2015: -$43.02M2016: -$55.14M2017: -$65.78M2018: -$101.25M2019: -$108.90M2020: -$182.81M2021: -$184.06M2022: -$247.12M2023: -$226.54M2024: -$88.88M2025: $263.86M$263.86M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$263.86M+396.9%2024-$88.88M+60.8%2023-$226.54M+8.3%2022-$247.12M-34.3%2021-$184.06M-0.7%2020-$182.81M-67.9%2019-$108.90M-7.6%2018-$101.25M-53.9%2017-$65.78M-19.3%2016-$55.14M-28.2%2015-$43.02M+4.8%2014-$45.19M-50.1%2013-$30.11M+23.0%2012-$39.08M+31.4%2011-$56.95M-68.2%2010-$33.85M-151.7%2009-$13.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share